Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Neuroendocrine Tumors × copper dotatate CU-64 × Clear all

Phase

Status

Sponsor Class

OTHER 3 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

olaparib 1 copper dotatate CU-64 1 Tomography, Emission-Computed, Single-Photon 1 Positron Emission Tomography Computed Tomography 1 PM 01183 1 Lutetium-177 1 Iodine-124 1 Iodine-123 1 Injections 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02125474 2019-11-14

Efficacy of 177-Lu-DOTA 0, Tyr 3 Octreotate

Instituto Nacional de Cancerologia, Columbia

Phase NA Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡